Show simple item record

dc.creatorWatson, Roryen
dc.date.accessioned2016-01-09T00:46:23Zen
dc.date.available2016-01-09T00:46:23Zen
dc.date.created2009-07-18en
dc.date.issued2009-07-18en
dc.identifier.bibliographicCitationBMJ: British Medical Journal 2009 July 18; 339(7713): 130en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=EC+berates+drug+industry+for+delays+in+access+to+generics&title=BMJ:+British+Medical+Journal+&volume=339&issue=7713&date=2009-07&au=Watson,+Roryen
dc.identifier.urihttp://hdl.handle.net/10822/1027503en
dc.formatArticleen
dc.languageenen
dc.sourceeweb:326479en
dc.subjectDrug Industryen
dc.subjectIndustryen
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationInternational and Political Dimensions of Biology and Medicineen
dc.subject.classificationBusiness Ethicsen
dc.titleEC Berates Drug Industry for Delays in Access to Genericsen
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885